Intra-tumour heterogeneity: a looking glass for cancer?, Nat. Rev. Cancer, vol.12, pp.323-357, 2012. ,
DOI : 10.1038/nrc3261
Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments, Transl. Oncol, vol.1, pp.158-64, 2008. ,
DOI : 10.1593/tlo.08178
URL : https://doi.org/10.1593/tlo.08178
Dissecting cancer evolution at the macroheterogeneity and micro-heterogeneity scale, Curr. Opin. Genet. Dev, vol.30, pp.1-6, 2015. ,
DOI : 10.1016/j.gde.2014.12.001
URL : https://doi.org/10.1016/j.gde.2014.12.001
Cancer as an evolutionary and ecological process, Nat. Rev. Cancer, vol.6, pp.924-959, 2006. ,
DOI : 10.1038/nrc2013
New dimensions of asymmetric division in vertebrates, Cytoskeleton, vol.75, pp.87-102, 2018. ,
Molecular mechanisms of asymmetric divisions in mammary stem cells, EMBO Rep, vol.17, pp.1700-1720, 2016. ,
Dormancy of mammary carcinoma after mastectomy, J. Natl. Cancer Inst, vol.91, pp.80-85, 1999. ,
DOI : 10.1093/jnci/91.1.80
URL : https://academic.oup.com/jnci/article-pdf/91/1/80/7794888/80.pdf
Mechanisms of metastatic tumor dormancy, J. Clin. Med, vol.2, pp.136-150, 2013. ,
DOI : 10.3390/jcm2030136
URL : http://www.mdpi.com/2077-0383/2/3/136/pdf
Reduced Latency in the metastatic niche contributes to the more aggressive phenotype of LM8 compared to Dunn osteosarcoma cells, Sarcoma, vol.2013, p.404962, 2013. ,
Occult tumor cells in bone marrow of patients with locoregionally restricted ovarian cancer predict early distant metastatic relapse, J. Clin. Oncol, vol.19, pp.368-75, 2001. ,
Detection and characterization of carcinoma cells in the blood, Proc. Natl. Acad. Sci. U.S.A, vol.95, pp.4589-4594, 1998. ,
Recent advances in technologies for the detection of occult metastatic cells in bone marrow of breast cancer patients, Breast Cancer Res, vol.3, pp.285-288, 2001. ,
Early cancer cell dissemination and late metastatic relapse: clinical reflections and biological approaches to the dormancy problem in patients, Semin. Cancer Biol, vol.11, pp.307-311, 2001. ,
Circulating tumor cells in patients with breast cancer dormancy, Clin. Cancer Res, vol.10, pp.8152-8162, 2004. ,
The isolation and characterization of CTC subsets related to breast cancer dormancy, Sci. Rep, vol.5, p.17533, 2015. ,
Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer, Sci. Transl. Med, vol.2, pp.25-48, 2010. ,
Cancer-associated mesenchymal stroma fosters the stemness of osteosarcoma cells in response to intratumoral acidosis via NF-?B activation, Int. J. Cancer, vol.140, pp.1331-1345, 2017. ,
The relationship between dormant cancer cells and their microenvironment, Adv. Cancer Res, vol.132, pp.45-71, 2016. ,
DOI : 10.1016/bs.acr.2016.07.002
URL : http://europepmc.org/articles/pmc5342905?pdf=render
Cells of origin in cancer, Nature, vol.469, pp.314-322, 2011. ,
Epigenetics and cancer stem cells: unleashing, hijacking, and restricting cellular plasticity, Trends Cancer, vol.3, pp.372-386, 2017. ,
DOI : 10.1016/j.trecan.2017.04.004
URL : https://doi.org/10.1016/j.trecan.2017.04.004
The role of CD133 in cancer: a concise review, Clin. Transl. Med, vol.7, p.18, 2018. ,
Cancer stem cells: Regulation programs, immunological properties and immunotherapy, Semin. Cancer Biol. In press ,
Eradicating cancer stem cells: concepts, issues, and challenges, Curr. Treat. Options Oncol, vol.19, p.20, 2018. ,
Cancer stem cells in osteosarcoma, Cancer Lett, vol.386, pp.189-195, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-01466078
Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy, Cancer Res, vol.69, pp.9245-9253, 2009. ,
Dormant glioblastoma cells acquire stem cell characteristics and are differentially affected by Temozolomide and AT101 treatment, Oncotarget, vol.8, pp.108064-108078, 2017. ,
Assessing stemness and proliferation properties of the newly established colon cancer 'stem' cell line, CSC480 and novel approaches to identify dormant cancer cells, Oncol. Rep. in press ,
Cancer stem cell in breast cancer therapeutic resistance, Cancer Treat. Rev, vol.69, pp.152-163, 2018. ,
Metastatic breast cancer cells enter into dormant state and express cancer stem cells phenotype under chronic hypoxia, J. Cell Biochem, vol.118, pp.3237-3248, 2017. ,
Prostate cancer stem cells: current understanding, Stem Cells in press ,
Lung cancer stem cells-origin2 characteristics and therapy, Stem Cell Investig, vol.5, p.6, 2018. ,
Oct4 plays a crucial role in the maintenance of gefitinib-resistant lung cancer stem cells, Biochem. Biophys. Res. Commun, vol.473, pp.125-132, 2016. ,
Stem cell characteristics of dormant cells and cisplatin-induced effects on the stemness of epithelial ovarian cancer cells, Mol. Med. Rep, vol.10, pp.2495-504, 2014. ,
,
Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells, Nat. Commun, vol.7, p.10690, 2016. ,
Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes/YAP axis, Clin Cancer Res, vol.20, pp.837-883, 2014. ,
The role of cancer stem cells in the modulation of anti-tumor immune responses, Semin. Cancer Biol. in press ,
Cancer stem cells: Regulation programs, immunological properties and immunotherapy, Semin. Cancer Biol. in press ,
Mathematical models of immune-induced cancer dormancy and the emergence of immune evasion, Interface Focus, vol.3, p.20130010, 2013. ,
Immunomodulating and immunoresistance properties of cancer-initiating cells: Implications for the Clinical Success of Immunotherapy, Immunol. Invest, vol.46, pp.221-238, 2017. ,
Immunobiological characterization of cancer stem cells isolated from glioblastoma patients, Clin. Cancer Res, vol.16, pp.800-813, 2010. ,
Immunology of cancer stem cells in solid tumours. A review, Eur. J. Cancer, vol.50, pp.649-55, 2014. ,
Evolution and phenotypic selection of cancer stem cells, PLoS Comput. Biol, vol.11, p.1004025, 2015. ,
The distribution of secondary growths in cancer of the breast, Cancer Metastasis Rev, vol.1889, pp.98-101, 1989. ,
Bone marrow sites differently imprint dormancy and chemoresistance to T-cell acute lymphoblastic leukemia, Blood Adv, vol.1, pp.1760-1772, 2017. ,
The bone marrow niche for haematopoietic stem cells, Nature, vol.505, pp.327-361, 2014. ,
Bone metastasis and the metastatic niche, J. Mol. Med. (Berl), pp.1203-1215, 2015. ,
The adaptive remodeling of stem cell niche in stimulated bone marrow counteracts the leukemic niche, Stem Cells in press ,
Metastatic niche functions and therapeutic opportunities, Nat. Cell Biol, vol.20, pp.868-877, 2018. ,
The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer, Oncotarget, vol.7, pp.41217-41232, 2016. ,
Osteoblast-secreted factors mediate dormancy of metastatic prostate cancer in the bone via activation of the TGF?RIII-p38MAPK-pS249/T252RB pathway, Cancer Res. In press ,
, gp130 Cytokine family and bone cells, vol.12, pp.1455-68, 2000.
Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow, Nat. Cell Biol, vol.18, pp.1078-1089, 2016. ,
Secreted protein acidic and rich in cysteine (SPARC) mediates metastatic dormancy of prostate cancer in bone, J. Biol. Chem, vol.291, pp.19351-19363, 2016. ,
Therapeutic antibody targeting tumor-and osteoblastic niche-derived jagged1 sensitizes bone metastasis to chemotherapy, Cancer Cell, vol.32, pp.731-747, 2017. ,
The hepatic microenvironment essentially determines tumor cell dormancy and metastatic outgrowth of pancreatic ductal adenocarcinoma, Oncoimmunol, vol.7, p.1368603, 2017. ,
The perivascular niche regulates breast tumor dormancy, Nat. Cell Biol, vol.15, pp.807-817, 2013. ,
The p53 family and the hypoxia-inducible factors (HIFs): determinants of cancer progression, Trends Biochem. Sci, vol.40, pp.425-459, 2015. ,
The acidic microenvironment as a possible niche of dormant tumor cells, Cell. Mol. Life Sci, vol.74, pp.2761-2771, 2017. ,
Lysyl oxidase is essential for hypoxia-induced metastasis, Nature, vol.440, pp.1222-1226, 2006. ,
Hoppe-Seyler F, Induction of dormancy in hypoxic human papillomavirus-positive cancer cells, Proc. Natl. Acad. Sci. U.S.A, vol.114, 2017. ,
Dormant tumor cells expressing LOXL2 acquire a stem-like phenotype mediating their transition to proliferative growth, Oncotarget, vol.7, pp.71362-71377, 2016. ,
Targeting metastasis-initiating cells through the fatty acid receptor CD36, Nature, vol.541, pp.41-45, 2017. ,
Mechanism of ECM-induced dormancy and chemoresistance in A549 human lung carcinoma cells, Oncol. Rep, vol.39, pp.1765-1774, 2018. ,
Evolutionary Genomics of Defense Systems in Archaea and Bacteria, Annu. Rev. Microbiol, vol.71, pp.233-261, 2017. ,
Persistent bacterial infections and persister cells, Nat. Rev. Microbiol, vol.15, pp.453-464, 2017. ,
Bacterial persister cell formation and dormancy, Appl. Environ. Microbiol, vol.79, pp.7116-7121, 2013. ,
Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies, J. Med. Microbiol, vol.60, pp.699-709, 2011. ,
A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations, Cell, pp.69-80, 2010. ,
A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth, Cell, vol.141, pp.583-94, 2010. ,
Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms, Trends Microbiol, vol.22, pp.326-359, 2014. ,
Ranking of persister genes in the same Escherichia coli genetic background demonstrates varying importance of individual persister genes in tolerance to different antibiotics, Front. Microbiol, vol.6, p.1003, 2015. ,
Latent tuberculosis: what the host "sees"?, Immunol. Res, vol.50, pp.202-214, 2011. ,
The human immune response to tuberculosis and its treatment: a view from the blood, Immunol. Rev, vol.264, pp.88-102, 2015. ,
Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids, Nature, vol.505, pp.218-240, 2014. ,
Bystander inhibition of dendritic cell differentiation by Mycobacterium tubercolisi-induced IL10, Immunol. Cell. Biol, vol.89, pp.437-446, 2011. ,
Mycobacterium tuberculosis infection of human monocyte-derived macrophages leads to apoptosis of T cells, Immunol. Cell. Biol, vol.87, pp.226-234, 2009. ,
Local bystander effect induces dormancy in human medullary thyroid carcinoma model in vivo, Cancer Lett, vol.335, pp.299-305, 2013. ,
Rescue of targeted nonstem-Like cells from bystander Stem-Like cells in human fibrosarcoma HT1080, Radiat. Res, vol.184, pp.334-340, 2015. ,
Epigenetic inheritance based evolution of antibiotic resistance in bacteria, BMC Evol. Biol, vol.8, p.52, 2008. ,
An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia, Nat. Genet, vol.46, pp.364-370, 2014. ,
Repression of stress-induced LINE-1 expression protects cancer cell subpopulations from lethal drug exposure, Cancer Cell, vol.32, pp.221-237, 2017. ,
The epigenetic/noncoding origin of tumor dormancy, Trends Mol. Med, vol.21, pp.206-211, 2015. ,
Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms, Trends Microbiol, vol.22, pp.326-359, 2014. ,
Persistent bacterial infections and persister cells, Nat. Rev. Microbiol, vol.15, pp.453-464, 2017. ,
Cancer drug resistance: an evolving paradigm, Nat. Rev. Cancer, vol.13, pp.714-726, 2013. ,
Tumor dormancy and relapse : from a natural bioproduct of evolution to a disease state, Cancer Res, vol.77, pp.2564-2569, 2017. ,
Dual function of pancreatic endoplasmic reticulum kinase in tumor cell growth arrest and survival, Cancer Res, vol.68, pp.3260-3268, 2008. ,
Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence, Nat Commun, vol.9, p.1944, 2018. ,
ER stress signaling promotes the survival of cancer "persister cells" tolerant to EGFR tyrosine kinase inhibitors, Cancer Res, vol.78, pp.1044-1057, 2018. ,
Distinct histone modifications denote early stress-induced drug tolerance in cancer, Oncotarget, vol.9, pp.8206-8222, 2017. ,
Cancer cells enter dormancy after cannibalizing mesenchymal stem/stromal cells (MSCs), Proc. Natl. Acad. Sci. U.S.A, vol.113, pp.6447-6456, 2016. ,
Clonal evolution in cancer, Nature, vol.481, pp.306-313, 2012. ,
Tumorigenesis: it takes a village, Nat. Rev. Cancer, vol.15, pp.473-83, 2015. ,
Re-evaluating clonal dominance in cancer evolution, Trends Cancer, vol.2, pp.263-276, 2016. ,
Turning ecology and evolution against cancer, Nat. Rev. Cancer, vol.14, pp.371-80, 2014. ,
The mathematics of cancer: integrating quantitative models, Nat. Rev. Cancer, vol.15, pp.730-775, 2015. ,
Mathematical modeling in cancer drug discovery, Drug Discov. Today, vol.19, pp.145-50, 2014. ,
A review of mathematical models of cancer-immune interactions in the context of tumor dormancy, Adv. Exp. Med. Biol, vol.734, pp.201-203, 2013. ,
Relating switching rates between normal and persister cells to substrate and antibiotic concentrations: a mathematical modelling approach supported by experiments, Microb. Biotechnol, vol.10, pp.616-1627, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01779031
Tracking the evolution of cancer cell populations through the mathematical lens of phenotype-structured equations, Biol. Direct, vol.11, p.43, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01321535
Drugtolerant persister cancer cells are vulnerable to GPX4 inhibition, Nature, vol.551, pp.247-250, 2017. ,
A transposon screen identifies loss of primary cilia as a mechanism of resistance to SMO inhibitors, Cancer Discov, vol.7, pp.1436-1449, 2017. ,